Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing’s family tumours

Grier, 2003, Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone, N Engl J Med, 348, 694, 10.1056/NEJMoa020890 Rodriguez-Galindo, 2003, Treatment of Ewing’s Sarcoma Family of Tumors: current status and outlook to the future, Med Pediatr Oncol, 40, 276, 10.1002/mpo.10240 Picci, 1997, Chemotherapy-induced tumor necrosis as prognostic factor in localized Ewing’s sarcoma of the extremities, J Clin Oncol, 15, 1553, 10.1200/JCO.1997.15.4.1553 Wheelan, 2004, Bone tumors, 371 Kolb, 2003, Long-term event-free survival after intensive chemotherapy for Ewing’s Family of Tumors in children and young adults, J Clin Oncol, 21, 3423, 10.1200/JCO.2003.10.033 Sandoval, 1996, Outcome in 43 children presenting with metastatic Ewing sarcoma. The St. Jude Children’s Research Hospital experience, from 1962 to 1992, Med Pediatr Oncol, 26, 180, 10.1002/(SICI)1096-911X(199603)26:3<180::AID-MPO6>3.0.CO;2-G Miser, 2004, Treatment of metastatic Ewing’s sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide – a Children’s Cancer Group and Pediatric Oncology Group Study, J Clin Oncol, 14, 2873, 10.1200/JCO.2004.01.041 Kushner, 2001, How effective is dose-intensive/myeloablative therapy against Ewing’s sarcoma/Primitive Neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review, J Clin Oncol, 19, 870, 10.1200/JCO.2001.19.3.870 Meyers, 2001, High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing’s sarcoma does not improve prognosis, J Clin Oncol, 21, 2812, 10.1200/JCO.2001.19.11.2812 Paulussen, 1998, Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies, Annals of Oncology, 9, 275, 10.1023/A:1008208511815 Samuels, 1995, High-dose intravenous melphalan: a review, J Clin Oncol, 13, 1786, 10.1200/JCO.1995.13.7.1786 Thacker, 2005, Current treatment for Ewing’s sarcoma, Expert Rev Anticancer Ther, 5, 319, 10.1586/14737140.5.2.319 Burdach, 2002, High-dose chemoradiotherapy (HDC) in the Ewing Family of Tumors (EFT), Critical Reviews in Oncology Haematology, 41, 169, 10.1016/S1040-8428(01)00154-8 Sarosy, 1988, The systemic administration of intravenous melphalan, J Clin Oncol, 11, 1768, 10.1200/JCO.1988.6.11.1768 Landenstein, 1995, Impact of megatherapy in children with high-risk Ewing’s tumours in complete remission: a report from the EBMT Solid Tumour Registry, Bone Marrow Transplantation, 15, 697 Graham-Pole, 1984, High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing’s sarcoma, Am J Pediatr Hematol Oncol, 6, 17 Cornbleet, 1981, Treatment of Ewing’s sarcoma with high-dose melphalan and autologous bone marrow transplantation, Cancer Treat Rep, 65, 241 Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors, J Natl Cancer Institute, 3, 205, 10.1093/jnci/92.3.205 Therasse, 2006, RECIST revised: a review of validation studies on tumour assessment, Eur J Cancer, 42, 1031, 10.1016/j.ejca.2006.01.026 http://ctep.cancer.gov/forms/CTCv20_4-30-992.pdf. Simon, 1985, Methodologic guidelines for reports of clinical trials, Cancer Treat Rep, 69, 1 Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Fata, 1999, Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face, Cancer, 86, 2034, 10.1002/(SICI)1097-0142(19991115)86:10<2034::AID-CNCR21>3.0.CO;2-P Hensley, 2002, Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial, J Clin Oncol, 20, 2824, 10.1200/JCO.2002.11.050 Horowitz, 1988, Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: a model for anticancer drug development, J Clin Oncol, 6, 308, 10.1200/JCO.1988.6.2.308 Ginsberg, 2002, Ewing’s sarcoma family of tumors: Ewing’s sarcoma of bone and soft tissue and the peripheral primitive neuroectodermal tumors, 973 Boccadoro, 2002, Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma, Haematologica, 87, 846 Perea, 2001, Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma, Annals of Hematology, 80, 592, 10.1007/s002770100351 Gupta, 2005, Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial, Bone Marrow Transplantation, 35, 441, 10.1038/sj.bmt.1704779